Pharmacovigilance in Russia: Challenges, Prospects and Current State of Affairs
- *Corresponding Author:
- Gildeeva GN
Pharmaceutical Science Department
Chair of Organization and Management in the Field of Drugs Circulation at the Sechenov First Moscow State Medical University, Russia
Tel: 8495656 27 17
E-mail: [email protected]
Received date: April 11, 2016; Accepted date: May 02, 2016; Published date: May 07, 2016
Citation: Gildeeva GN, Yurkov VI (2016) Pharmacovigilance in Russia: Challenges, Prospects and Current State of Affairs. J Pharmacovigil 4:206. doi: 10.4172/2329-6887.1000206
Copyright: © 2016 Gildeeva GN, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This review provides an insight into the main historical milestones of development and narrates on current state of affairs of the system of pharmacological vigilance in Russia. Specific focus has been made on topical issues related to functioning of the system designed to monitor drugs safety nowadays: regular procedures in the field of pharmacovigilance in the Russian Federation, reporting and accountability of pharmaceutical products manufacturers and medical staff, the role played by regional centres for drugs safety monitoring, insufficient understanding of the part taken by patients/consumers in the system of pharmacovigilance, lack of adequate surveillance over safe use of drugs during pregnancy. Further to the foregoing, appropriate consideration has been given to the prospects of Russian pharmacovigilance and its harmonization with global practice.